Justia Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

For example, Spravato, Janssen Pharmaceutical’s intranasal S-ketamine product, comes with a REMS that mandates the product can only be given in an approved facility. [read post]

Bill of Health - https://blog.petrieflom.law.harvard.edu/

Federal Court of Appeal Examines the Scope of the Implied License to Use a Patented Article

21 Feb 2024, 4:00 am by Martin Kratz

Janssen Inc., 2024 FCA 10 at para 16 citing Thomas v. [read post]

Slaw - http://www.slaw.ca/

Federal Circuit Affirms Invalidity of Genus Claims to Stevia Production Method Lacking Written Description and Narrower Claims as Combining Natural Phenomena with an Abstract Idea

4 Jan 2024, 9:42 am by Dennis Crouch

Janssen Biotech, Inc., 759 F.3d 1285 (Fed. [read post]

Patently-O - https://patentlyo.com

The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients

20 Dec 2023, 5:00 am by Timothy Bonis

Janssen 2014). [read post]

Bill of Health - https://blog.petrieflom.law.harvard.edu/

The Case for Procurement Transparency

12 Dec 2023, 5:00 am by The Petrie-Flom Center Staff

The disclosure of the records, and subsequent analysis thereof led by the HJI have revealed that not only was South Africa charged more for COVID-19 vaccines than countries in the Global North, but also that the terms and conditions that the state had to agree to were overwhelmingly one-sided, favouring multinational pharmaceutical companies (including Janssen Pharmaceuticals, which produces the J&J vaccine, as well as with Pfizer, and the Serum Institute of India) and… [read post]

Bill of Health - https://blog.petrieflom.law.harvard.edu/

Don’t Be Too Alarmed by the New SCOTUS Antibody Ruling

8 Dec 2023, 7:58 am by Timothy Bonis

Janssen, 2014). [read post]

Bill of Health - https://blog.petrieflom.law.harvard.edu/

A Difficult Test for Inducing Patent Infringement

1 Dec 2023, 4:00 am by Martin Kratz

Janssen Inc., 2023 FCA 220 at para 4. [2] See Corlac Inc. v. [read post]

Slaw - http://www.slaw.ca/

The DTSA Ex Parte Seizure Provision Was Always Bad Policy–Janssen v. Evenus

28 Oct 2023, 8:44 am by Eric Goldman

Case Citation: Janssen Products LP v. [read post]

Technology & Marketing Law Blog - http://blog.ericgoldman.org/

Preliminary Injunction Decision in Chambers of Commerce Case Provides First Insights Into Merits of Medicare Negotiations Cases

4 Oct 2023, 10:00 pm by Kurt R. Karst

The Plaintiffs argued the unconstitutionality of the Medicare Negotiation Program under the Fifth Amendment by relying on Michigan Bell v. [read post]

FDA Law Blog - https://www.thefdalawblog.com/

Counterclaim Against Non-Asserted Claims Is Permitted as of Right Under the Patented Medicines (NOC) Regulations

12 Apr 2023, 4:00 am by Martin Kratz

Sandoz Canada Inc., 2023 FC 243 at para 6 quoting from the Regulatory Impact Analysis Statement, (2017) Canada Gazette, Part 1, Vol 151, No 28 at 3317. [3] See Section 7(1)(d), Patented Medicines (NOC) Regulations. [4] See Section 6(3), Patented Medicines (Notice of Compliance) Regulations, subsections (a0 and (b) provide for a counterclaim against asserted claims in a patent or in a certificate of supplementary protection respectively. [5] See Janssen Inc v Apotex Inc, 2022 FCA… [read post]

Slaw - http://www.slaw.ca/

DNJ Court Grants Motion to Dismiss Based on Covenant Not to Sue

5 Dec 2022, 6:55 am by Charles H. Chevalier and Christine A. Gaddis

The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]

Employment Law Alert - http://www.employmentlawalert.com

DNJ Court Grants Motion to Dismiss Based on Covenant Not to Sue

5 Dec 2022, 6:55 am by Charles H. Chevalier and Christine A. Gaddis

The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]

IP Law Alert - http://www.iplawalert.com